15
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
SU011248
50 mg/day orally for 4 weeks, no treatment for 2 weeks (6 weeks = 1 cycle).
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Pfizer
INDUSTRY
M.D. Anderson Cancer Center
OTHER